Smoking and tea consumption delay onset of Parkinson's disease

被引:69
作者
Kandinov, Boris [1 ]
Giladi, Nir [2 ,3 ]
Korczyn, Amos D. [1 ,2 ,3 ]
机构
[1] Tel Aviv Univ, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Dept Neurol, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel
关键词
Parkinson's disease; Coffee; Tea; Smoking; Age of onset; Pack-years; Cup-years; Neuroprotection; ENVIRONMENTAL RISK-FACTORS; CIGARETTE-SMOKING; ALCOHOL-CONSUMPTION; CLINICAL-DIAGNOSIS; COFFEE CONSUMPTION; CAFFEINE; NICOTINE; ASSOCIATION; PROGRESSION; INHIBITION;
D O I
10.1016/j.parkreldis.2008.02.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cigarette smoking, coffee and tea drinking may protect against Parkinson's disease (PD). These factors were assessed, retrospectively, to measure their effect on the age of PD onset. The study population consisted of 278 consecutive PD patients. smoking ! 10 pack-years delayed age of PD onset by 3.2 years (p < 0.05). Consumption of tea more than 3 cups per day delayed age of motor symptoms onset by 7.7 years (p < 0.01). Coffee consumption exceeding 3 cups per day advanced the age of PD onset by 4.8 years (p = 0.03). Thus, tea consumption and smoking can delay the age of PD onset, while coffee drinking may have the opposite effect. (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 64 条
  • [41] Neuroprotection and neurorescue against Aβ toxicity and PKC-dependent release of non-amyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate
    Levites, Y
    Amit, T
    Mandel, S
    Youdim, MBH
    [J]. FASEB JOURNAL, 2003, 17 (03) : 952 - +
  • [42] Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration
    Levites, Y
    Weinreb, O
    Maor, G
    Youdim, MBH
    Mandel, S
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 78 (05) : 1073 - 1082
  • [43] In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases
    Linert, W
    Bridge, MH
    Huber, M
    Bjugstad, KB
    Grossman, S
    Arendash, GW
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1999, 1454 (02): : 143 - 152
  • [44] Environmental risk factors and Parkinson's disease: A case-control study in Taiwan
    Liou, HH
    Tsai, MC
    Chen, CJ
    Jeng, JS
    Chang, YC
    Chen, SY
    Chen, RC
    [J]. NEUROLOGY, 1997, 48 (06) : 1583 - 1588
  • [45] MARTTILA RJ, 1980, ACTA NEUROL SCAND, V62, P322
  • [46] Nicotine prevents glutamate-induced proteolysis of the microtubule-associated protein MAP-2 and glutamate neurotoxicity in primary cultures of cerebellar neurons
    Miñana, MD
    Montoliu, C
    Llansola, M
    Grisolía, S
    Felipo, V
    [J]. NEUROPHARMACOLOGY, 1998, 37 (07) : 847 - 857
  • [47] MORANO A, 1994, ACTA NEUROL SCAND, V89, P164
  • [48] A RETROSPECTIVE STUDY OF SMOKING IN PARKINSONS DISEASE
    NEFZGER, MD
    QUADFASEL, FA
    KARL, VC
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1968, 88 (02) : 149 - +
  • [49] Etiology and Pathogenesis of Parkinson's Disease
    Schapira, Anthony H.
    Jenner, Peter
    [J]. MOVEMENT DISORDERS, 2011, 26 (06) : 1049 - 1055
  • [50] Parkinson's disease and environmental factors - Matched case-control study in the Limousin region, France
    Preux, PM
    Condet, A
    Anglade, C
    Druet-Cabanac, M
    Debrock, C
    Macharia, W
    Couratier, P
    Boutros-Toni, F
    Dumas, M
    [J]. NEUROEPIDEMIOLOGY, 2000, 19 (06) : 333 - 337